ClinConnect ClinConnect Logo
Search / Trial NCT05649644

Sensorimotor Block Dynamics and Hemidiaphragmatic Palsy: Selective Trunk Block vs Supraclavicular Brachial Plexus Block

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 5, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sensorimotor Block Dynamics Hemidiaphragmatic Palsy Upper Extremity Surgery Selective Trunk Block Supraclavicular Brachial Plexus Block

ClinConnect Summary

This clinical trial is studying two different methods of providing anesthesia for surgeries on the upper arm and hand. Researchers want to compare the effectiveness of a technique called selective trunk block (SeTB) to a more commonly used method known as supraclavicular brachial plexus block (BPB). They believe that SeTB may do a better job of numbing the entire arm, from the shoulder down to the hand, without causing certain side effects that can occur with the BPB method.

To participate in this trial, individuals aged between 18 and 75 who are scheduled for either elective or emergency surgery on their upper extremity may be eligible. However, some people may not qualify if they are pregnant, have certain skin infections, or have specific health issues such as respiratory problems or an allergy to local anesthesia. Participants can expect to receive either of the two anesthesia techniques during their surgery, and the study aims to gather important information on how well each technique works. Overall, this research could help improve pain management for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA 1-3 patients
  • Undergoing elective or emergency upper extremity surgery involving anywhere from the proximal humerus to distal hand or surgery involving any combination of these regions
  • Exclusion Criteria:
  • Patient refusal
  • Pregnancy
  • Skin infection at the site of block placement
  • History of allergy to local anaesthetic (LA) drugs
  • Bleeding tendency or with evidence of coagulopathy
  • Pre-existing respiratory disease
  • Neurological deficit or neuromuscular disease.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Manoj K Karmakar, MD

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials